Glen Mills, PA, United States of America

Benjamin J Dugan

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Glen Mills, PA (US) (2000 - 2019)
  • West Chester, PA (US) (2021)

Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Benjamin J. Dugan

Introduction

Benjamin J. Dugan, a prominent inventor based in Glen Mills, Pennsylvania, has made significant contributions to the field of pharmaceuticals. With 13 patents to his name, he has developed innovative compounds and methods that address critical health challenges, particularly in the realms of oncology and cell regulation.

Latest Patents

Among Benjamin Dugan's most recent patents is a groundbreaking invention related to the "Preparation and uses of pyrimidinone derivatives." This patent discusses compounds that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. These compounds hold promise in the treatment of proliferative disorders, including cancer, emphasizing the importance of Cdc7 kinase activity in various diseases.

In addition, Dugan has developed "Azaquinazoline inhibitors of atypical protein kinase C." This patent highlights compounds that exhibit aPKC inhibitory activity, offering potential therapeutic applications for proliferative disorders as well. Through these innovations, Dugan continues to push the boundaries of pharmaceutical research and development.

Career Highlights

Dugan has collaborated with notable companies throughout his career, including FMC Corporation and Cephalon, Inc. His work with these organizations has significantly impacted the pharmaceutical industry, resulting in the advancement of treatments that target complex health issues. Benjamin's expertise and innovative spirit have established him as a respected figure in his field.

Collaborations

Throughout his career, Benjamin J. Dugan has worked alongside esteemed colleagues, including Bruce D. Dorsey and Eugen F. Mesaros. These collaborations have enriched his research endeavors, leading to the successful development of various patents and furthering the knowledge base in the pharmaceutical industry.

Conclusion

In summary, Benjamin J. Dugan's work exemplifies the spirit of innovation and dedication to improving human health through inventive pharmaceutical solutions. His contributions, particularly in the development of inhibitors related to critical kinase activities, underscore the impact of his research on the future of medicine. With each patent, he continues to pave the way for new therapeutic approaches, demonstrating the profound influence of diligent inventors in the world today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…